KZIA240816C2500
- 0.05
- 0.000.00%
Kazia Therapeutics Newsroom
ADRs End Lower; Kazia Therapeutics Ltd. Declines 18%
Kazia Therapeutics KZIA +248% Phase 2/3 Data; Longeveron LGVN +59% RMAT Designation
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Nasdaq Surges 1%; JPMorgan Posts Upbeat Earnings
Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why
Dow Jumps 100 Points; Producer Inflation Surpasses Expectations For June
HC Wainwright & Co. Reiterates Buy on Kazia Therapeutics, Maintains $2 Price Target
Kazia Therapeutics Analyst Ratings
H.C. Wainwright Maintains Kazia Therapeutics(KZIA.US) With Buy Rating, Maintains Target Price $2
Buy Rating on Kazia Therapeutics Backed by Promising GBM Study Results and Strong Financial Valuation
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
What's Going On With Kazia Therapeutics Shares Thursday?
Express News | Kazia Therapeutics Shares Resume Trade Following Circuit Breaker Halt
US Stocks Edge Higher; Inflation Slows To 3% In June
Trending Stocks Today: Volcon Shoots up 76.71% Pre-Market
Kazia Therapeutics Stocks Soar Following Phase II/III Win
Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Trending Stocks Today: MingZhu Logistics Soars 68.05% Post-Market
ADRs Close Higher; Kazia Therapeutics Ltd. Climbs 248%